l‐DOPA Up‐Regulates Glutathione and Protects Mesencephalic Cultures Against Oxidative Stress

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Neurochemistry

• Publication date

  1996-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1046/j.1471-4159.1996.66020501.xPMID 8592119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem

  2005cited by this paper
• l‐DOPA Cytotoxicity to PC12 Cells in Culture Is via Its Autoxidation

  1995cited by this paper
• gamma-Glutamylcysteine synthetase and GSH increase in quinone-induced oxidative stress in BPAEC.

  1994cited by this paper
• The time-course of mixed disulfide formation between GSH and proteins in rat blood after oxidative stress with tert-butyl hydroperoxide.

  1994cited by this paper
• Characterization of quinone reductase, glutathione and glutathione S-transferase in human myeloid cell lines: induction by 1,2-dithiole-3-thione and effects on hydroquinone-induced cytotoxicity.

  1994cited by this paper
• Vitamin E, Ascorbate, Glutathione, Glutathicne Disulfide, and Enzymes of Glutathione Metabolism in Cultures of Chick Astrocytes and Neurons: Evidence that Astrocytes Play an Important Role in Antioxidative Processes in the Brain

  1994cited by this paper
• Metals and free radicals in neurodegeneration.

  1994cited by this paper
• Toxic and Protective Effects of l‐DOPA on Mesencephalic Cell Cultures

  1993cited by this paper
• Cystine Uptake and Glutathione Level in Fetal Brain Cells in Primary Culture and in Suspension

  1993cited by this paper
• Damage to Neurons in Culture Following Medium Change: Role of Glutamine and Extracellular Generation of Glutamate

  1993cited by this paper
• Maintenance of Neuronal Glutathione by Glial Cells

  1993cited by this paper
• Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid

  1993cited by this paper
• Astroglia-neuron interactions that promote long-term neuronal survival.

  1993cited by this paper
• High-performance liquid chromatography (HPLC) analysis of eu- and pheomelanin in melanogenesis control.

  1993cited by this paper
• Glutathione peroxidase, glial cells and Parkinson's disease.

  1993cited by this paper
• Oxidative stress and thiol modification induced by chronic administration of haloperidol.

  1993cited by this paper
• The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it

  1992cited by this paper
• Enhancement of gamma-glutamylcysteine synthetase mRNA in rat kidney by methyl mercury.

  1992cited by this paper
• Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy.

  1991cited by this paper
• Increased excitotoxic vulnerability of cortical cultures with reduced levels of glutathione.

  1991cited by this paper
• Locally formed dopamine stimulates cAMP accumulation in LLC-PK1 cells via a DA1 dopamine receptor.

  1991cited by this paper
• Glutathione deficiency leads to mitochondrial damage in brain.

  1991cited by this paper
• Protective effect of prostaglandin A2 against menadione-induced cell injury in cultured porcine aorta endothelial cells.

  1991cited by this paper
• Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence.

  1991cited by this paper
• Glutathione: toxicological implications.

  1990cited by this paper
• Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons.

  1990cited by this paper
• Superoxide dismutase and Parkinson's disease.

  1990cited by this paper
• Cytoskeleton as a target in menadione‐induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features

  1990cited by this paper
• Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture

  1990cited by this paper
• Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases.

  1990cited by this paper
• Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons.

  1989cited by this paper
• Induction of cystine transport activity in human fibroblasts by oxygen.

  1989cited by this paper
• Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor.

  1989cited by this paper
• A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra

  1989cited by this paper
• Catecholamine toxicity in cerebral cortex in dissociated cell culture

  1988cited by this paper
• Histochemical evaluation of glutathione in brain.

  1987cited by this paper
• Glutathione depletion and susceptibility.

  1984cited by this paper
• Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes.

  1984cited by this paper
• Glutathione.

  1983cited by this paper
• Genetic toxicity of dopamine.

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).

  1983cited by this paper
• Catalase, Glutathione Peroxidase, Superoxide Dismutase, and Cytochrome P-450

  1983cited by this paper
• Growth of a rat neuroblastoma cell line in serum-free supplemented medium.

  1979cited by this paper
• Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro.

  1978cited by this paper
• Alpah-adrenergic receptor modulation of beta-adrenergic, adenosine and prostaglandin E1 increased adenosine 3':5'-cyclic monophosphate levels in primary cultures of glia.

  1978cited by this paper
• Regulation of the synthesis of superoxide dismutase in Escherichia coli. Induction by methyl viologen.

  1977cited by this paper
• Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis.

  1976cited by this paper
• 6-Hydroxydopamine: Evidence for Superoxide Radical as an Oxidative Intermediate

  1973cited by this paper
• The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase.

  1972cited by this paper
• LACTIC DEHYDROGENASE.

  1964cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Liquiritin and L-Dopa mitigate gaseous elemental mercury toxicity in Tillandsia usneoides: Insights into metabolic reprogramming and phytoremediation potential.

  2025cites this paper
• Ultrasensitive and Selective Iontronic H2O2 Nanosensor Reveals the Biphasic Redox Dynamics Invoked by l-DOPA at a Single-Cell Level.

  2025cites this paper
• Nanostructures based on gold and silica as a delivery platform for enhanced L-DOPA therapy in neurodegenerative disease.

  2025cites this paper
• L-DOPA Promotes Functional Proliferation Through GPR143, Specific L-DOPA Receptor of Astrocytes.

  2024cites this paper
• Thioketal-Based Electrochemical Sensor Reveals Biphasic Effects of l-DOPA on Neuroinflammation.

  2024cites this paper
• Dopamine receptor agonist pramipexole exerts neuroprotection on global cerebral ischemia/reperfusion injury by inhibiting ferroptosis.

  2024cites this paper
• Role of dopamine in the pathophysiology of Parkinson’s disease

  2023cites this paper
• The Effect of Lactobacillus sakei on Growth Performance and Intestinal Health in Dogs: Gut Microbiota and Metabolism Study

  2023cites this paper
• Neurodegenerative Etiology of Aromatic L-Amino Acid Decarboxylase Deficiency: a Novel Concept for Expanding Treatment Strategies

  2023influential citation
• Preventive effect of levodopa on vitiligo development: a nationwide case–control study

  2022cites this paper
• Impairment of neuronal mitochondrial function by l-DOPA in the absence of oxygen-dependent auto-oxidation and oxidative cell damage

  2021cites this paper
• Probiotic Supplementation Facilitates Recovery of 6-OHDA-Induced Motor Deficit via Improving Mitochondrial Function and Energy Metabolism

  2021cites this paper
• Intracerebroventricular administration of dopamine in Parkinson's disease: treatment of motor fluctuations and dyskinesia

  2020cites this paper
• Eugenol and its association with levodopa in 6‐hydroxydopamine‐induced hemiparkinsonian rats: Behavioural and neurochemical alterations

  2020cites this paper
• [New Therapeutic Options for the Individualised Titration of Levodopa].

  2020cites this paper
• Levodopa is the best symptomatic therapy for PD: Nothing more, nothing less

  2019cites this paper
• The “Long and Winding Road” of the Disease‐Modifying Effects of Levodopa Has Not Ended Yet

  2019cites this paper
• Mushroom-Mediated Protection from Oxidative Damage to DNA

  2018cites this paper
• Molecular basis of dopamine replacement therapy and its side effects in Parkinson’s disease

  2018cites this paper
• Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress

  2017cites this paper
• Effect of D‐Ala2GIP, a stable GIP receptor agonist on MPTP‐induced neuronal impairments in mice

  2017cites this paper
• Targeting urate to reduce oxidative stress in Parkinson disease.

  2017cites this paper
• Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity.

  2017cites this paper
• 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of l-DOPA

  2016cites this paper
• l‐DOPA‐induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?

  2016influential citation
• Unmasking levodopa resistance in Parkinson's disease

  2016cites this paper
• Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited.

  2016cites this paper
• Characterization and Expression of Chicken Selenoprotein U

  2015cites this paper
• Evaluation of Levodopa and Carbidopa Antioxidant Activity in Normal Human Lymphocytes In Vitro: Implication for Oxidative Stress in Parkinson’s Disease

  2015cites this paper
• Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity.

  2015cites this paper
• Synthesis and antioxidant activity of DOPA peptidomimetics by a novel IBX mediated aromatic oxidative functionalization

  2015cites this paper
• Levodopa: Effect on cell death and the natural history of Parkinson's disease

  2015cites this paper
• Low-Dose Levodopa Protects Nerve Cells from Oxidative Stress and Up-Regulates Expression of pCREB and CD39

  2014cites this paper
• Identification of novel therapeutic targets and evaluation of pharmacological treatments in epigenetic and chromatin diseases- the case of Rett syndrome

  2014cites this paper
• Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons

  2014cites this paper
• Evaluation of the Cytotoxicity of Levodopa and its Complex with Hydroxypropyl-ß-Cyclodextrin (HP-ß-CD) to an Astrocyte Cell Line.

  2014cites this paper
• Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.

  2014cites this paper
• Organ Specific Killing af a Dispensable Organ or a Cell Population in an Organ - a Successful Design for Cancer Therapy - a Hypothesis

  2014cites this paper
• Glial-Neuronal Interactions during Oxidative Stress Implications for Parkinson’s Disease

  2013cites this paper
• Progress Towards Understanding Of Mechanisms Of Action Of Potent Multifunctional Disease Modifying Therapeutics For Parkinson's Disease & Investigating The Methamphetamine-Induced Striatal Microglia Activation.

  2013cites this paper
• Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states.

  2013influential citation
• Lewodopa w leczeniu choroby Parkinsona – wczoraj i dziś

  2012cites this paper
• Enhancing dopamine treatments: worth the effort?

  2012cites this paper
• Recent advances in pharmacological therapy of Parkinson's disease: levodopa and carbidopa protective effects against DNA oxidative damage

  2012cites this paper
• [Levodopa in the treatment of Parkinson disease -- yesterday and today].

  2012cites this paper
• [Levodopa in the treatment of Parkinson's disease: myths and realties].

  2012cites this paper
• Protective Effects of L-Dopa and Carbidopa Combined Treatments on Human Catecholaminergic Cells

  2012cites this paper
• Levodopa en el tratamiento de la enfermedad de Parkinson: mitos y realidades

  2012cites this paper
• The neurochemical consequences of aromatic L-amino acid decarboxylase deficiency

  2011cites this paper
• Characterization and expression of chicken selenoprotein W

  2011cites this paper
• L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson's disease?

  2011cites this paper
• Protective effects of the crude extracts from yam (Dioscorea alata) peel on tert-butylhydroperoxide-induced oxidative stress in mouse liver cells

  2011cites this paper
• In vitro S100B secretion is reduced by apomorphine: effects of antipsychotics and antioxidants.

  2011cites this paper
• Radical sequestration by protein-bound 3,4-dihydroxyphenylalanine.

  2010cites this paper
• EFECTO DE LA ADMINISTRACIÓN CRÓNICA DE LEVODOPA SOBRE LA ACTIVIDAD FUNCIONAL DE LA VÍA NIGROESTRIADA EN MACACOS CON PARKINSONISMO INDUCIDO POR MPTP

  2010cites this paper
• Estudio de las vías de supervivencia y muerte neuronal en modelos de la enfermedad de Huntington

  2010cites this paper
• Dopamine Receptors and the Treatment of Parkinson's Disease

  2010cites this paper
• The protective action of topiramate on dopaminergic neurons.

  2010cites this paper
• Mechanisms of L-DOPA-induced cytotoxicity in rat adrenal pheochromocytoma cells: implication of oxidative stress-related kinases and cyclic AMP.

  2010cites this paper
• [Levodopa: from a discovery to new elaborations].

  2010cites this paper
• Half a century of L-DOPA.

  2009cites this paper
• The scientific and clinical basis for the treatment of Parkinson disease (2009)

  2009cites this paper
• Taurine inhibition of metal-stimulated catecholamine oxidation

  2009cites this paper
• Neuroprotective effect of l‐dopa on dopaminergic neurons is comparable to pramipexol in MPTP‐treated animal model of Parkinson’s disease: a direct comparison study

  2009cites this paper
• Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats

  2009cites this paper
• Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease.

  2009cites this paper
• Hepatoprotection of chlorella against carbon tetrachloride-induced oxidative damage in rats.

  2009cites this paper
• Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.

  2009cites this paper
• Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.

  2008cites this paper
• Effects of Graptopetalumparaguayense extract on tert- butylhydroperoxide-induced oxidative stress

  2008cites this paper
• Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson’s disease

  2008cites this paper
• Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.

  2008cites this paper
• The effects of L-3,4-dihydroxyphenylalanine and dopamine agonists on dopamine neurons in the progressive hemiparkinsonian rat models

  2007cites this paper
• 15 Glutathione in the Nervous System: Roles in Neural Function and Health and Implications for Neurological Disease

  2007cites this paper
• Naturally occurring tyrosinase inhibitors: mechanism and applications in skin health, cosmetics and agriculture industries

  2007influential citation
• When Should Levodopa Therapy be Initiated in Patients with Parkinson’s Disease?

  2007cites this paper
• BEATING A DEAD HORSE: DOPAMINE AND PARKINSON DISEASE

  2007cites this paper
• Beating a dead horse

  2007cites this paper
• Effects of sodium arsenite on catalase activity, gene and protein expression in HaCaT cells.

  2006cites this paper
• Levodopa for the treatment of Parkinson’s disease: current perspectives

  2006cites this paper
• Reply

  2006cites this paper
• Transient glucose and amino acid deprivation induces delayed preconditioning in cultured rat cortical neurons

  2006cites this paper
• PAPEL DE LA PROTEÍNA PARKINA EN LA FUNCIÓN CELULAR DE LAS NEURONAS DOPAMINÉRGICAS. SUSCEPTIBILIDAD A LA MUERTE CELULAR

  2006cites this paper
• Synergistic effect of α-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture

  2006cites this paper
• Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage.

  2006cites this paper
• Dopamine activates Nrf2‐regulated neuroprotective pathways in astrocytes and meningeal cells

  2006cites this paper
• Treatment should not be initiated too soon in Parkinson's disease

  2006cites this paper
• Consumption of redox energy by glutathione metabolism contributes to hypoxia/ reoxygenation-induced injury in astrocytes

  2006cites this paper
• Optimising levodopa therapy for the management of Parkinson’s disease

  2005cites this paper
• Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction.

  2005cites this paper
• Levodopa therapy from the neuroprotection viewpoint

  2005cites this paper
• Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease

  2005cites this paper
• Optimising levodopa therapy for the management of Parkinson’s disease

  2005cites this paper
• Mechanism of cytotoxicity of catechols and a naphthalenediol in PC12-AC cells: the connection between extracellular autoxidation and molecular electronic structure.

  2005cites this paper
• Levodopa therapy from the neuroprotection viewpoint

  2005cites this paper
• Enhanced Toxicity to the Catecholamine Tyramine in Polyglutamine Transfected SH-SY5Y Cells

  2005cites this paper
• Neuroprotective and Neurotoxic Effects of L-DOPA in Rat Midbrain Dopaminergic Neurons in Culture

  2005cites this paper
• Dopamine et dégénérescence des neurones striataux dans la maladie de Huntington : vers l'identification de nouvelles cibles thérapeutiques

  2005cites this paper
• Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

  2005cites this paper
• Differential effects of l‐DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal‐enriched cultures from parkin knockout and wild‐type mice

  2005influential citation